Table 2.
Brands (No. positive) | Pattern of antibiotic resistance (%) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AM10* | Met5 | ER5 | CLR2 | AMX 10 | Lev5 | Cef30 | TRP25 | FZL1 | Mox5 | Tin4 | CIP5 | |
A (1) | 1 (100)a | 1 (100)a | 1 (100)a | 1 (100)a | 1 (100)a | - | - | - | - | - | - | - |
B (1) | 1 (100)a | 1 (100)a | 1 (100)a | 1 (100)a | 1 (100)a | 1 (100)a | - | 1 (100)a | - | - | 1 (100)a | 1 (100)a |
C (4) | 2 (50)a | 2 (50)a | 2 (50)a | 2 (50)a | 2 (50)a | 2 (50)a | 1 (25)b | 3 (75)a | 1 (25)b | 1 (25)b | 2 (50)a | 2 (50)a |
D (2) | 2 (100)a | 1 (50)a | 1 (50)a | 1 (50)a | 1 (50)a | 1 (50)a | 1 (50)b | 1 (50)a | 1 (50)b | 1 (50)b | 1 (50)a | 1 (50)a |
Total (8) | 6 (75)a, * | 5 (62.5)a | 5 (62.5)a | 5 (62.5)a | 5 (62.5)a | 4 (50)a | 2 (25)b | 5 (62.5)a | 2 (25)b | 2 (25)b | 4 (50)a | 4 (50)a |
*AM10: ampicillin (10 μg), Met5: metronidazole (5 μg), ER5: erythromycin (5 μg), CLR2: clarithromycin (2 μg), AMX10: amoxicillin (10 μg), Lev5: levofloxacin (5 μg), Cef30: cefsulodin (30 μg), TRP25: trimethoprim (25 μg), FZL1: furazolidone (1 μg), Mox5: moxifloxacin (5 μg), Tin: tinidazole (prepared from pure powders, Sigma, 5 μg) and CIP5: ciprofloxacin (5 μg)
a, bDissimilar letters in each row shows significant differences about P <0.05